BioStock: Evaxion Biotech Secures Equity Financing of up to 40 MUSD

Evaxion’s use of artificial intelligence platforms to develop new cancer drugs has caught the eye Lincoln Park Capital, a Chicago-based asset management firm. The Danish biotech has announced an agreement with the firm, securing access to up to 40 MUSD.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/06/evaxion-biotech-secures-equity-financing-of-up-to-40-musd/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/